Home - Products - Others - Other Targets - Bronopol

Bronopol

CAS No. 52-51-7

Bronopol( —— )

Catalog No. M14857 CAS No. 52-51-7

Bronopol is a Standardized Chemical Allergen. The physiologic effect of bronopol is by means of Increased Histamine Release and Cell-mediated Immunity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
50MG	32	In Stock
100MG	42	In Stock
200MG	57	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Bronopol
Note

Research use only, not for human use.
Brief Description

Bronopol is a Standardized Chemical Allergen. The physiologic effect of bronopol is by means of Increased Histamine Release and Cell-mediated Immunity.
Description

Bronopol is a Standardized Chemical Allergen. The physiologic effect of bronopol is by means of Increased Histamine Release and Cell-mediated Immunity. The chemical classification of bronopol is Allergens.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

Infection
Indication

——

Chemical Information

CAS Number

52-51-7
Formula Weight

199.99
Molecular Formula

C3H6NO4Br
Purity

>98% (HPLC)
Solubility

DMSO: 10 mM
SMILES

OCC(Br)(CO)[N+]([O-])=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Matczuk M, et al. Int J Cosmet Sci. 2012 Oct;34(5):451-7.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Glyasperin C

Glyasperin C acts as a partial estrogen antagonist, it shows tyrosinase inhibitory activity (IC (50) = 0.13 +/- 0.01 microg/mL), it could be a promising candidate in the design of skin-whitening agents. Glyasperin C shows potent anti-vancomycin-resistant Enterococci effects (MIC 1.9 × 10-5-4.5 × 10-5 M for E. faecium and E. faecalis).
Lucerastat

A galactose analogue that is an UDP-glucose ceramide glucosyltransferase (UGCG/GCS) inhibitor (IC50=41.4 uM).
GNF2133

GNF2133 is an effective and selective inhibitor of DYRK1A with IC50s of 6.2 nM. GNF2133 can be used in studies about type 1 diabetes.

Sign In Join Free